Abstract
Neuroblastoma is the most common malignant intra-abdominal tumor in children. The incidence rate of neuroblastoma (including ganglioneuroblastoma) was 9.4 cases per million U.S. white children less than 15 years of age per year. The corresponding figure for U.S. black children was 7.1 605, The highest rate was 12.0 among boys in Torino, Italy. The lowest rate was 4.4 among U.S. black girls (Table 1) 38,39,119,151,365,366,407,548,604,606.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abercrombie J: Multiple sarcomata of cranial bones. Trans Pathol Soc London 31:216–223, 1880.
Abilgaard CF: Unique features of metastatic neuroblastoma in the bone marrow. Am J Clin Pathol 74:363–364, 1980.
Ablin AR, Bleyer WA, Finklestein JZ, Hartmann JR, Leikin S and Hammond GD: Failure of moderate-dose prolonged infusion methotrexate and citrovorum factor rescue in patients with previously treated metastatic neuroblastoma — A phase II study. Cancer Treat Rep 62:1097–1099, 1978.
Adam A and Hochholzer L: Ganglioneuroblastoma of the posterior mediastinum: A clinicopathologic review of 80 cases. Cancer 47:373–381, 1981.
Addanki S, Gombos RL, Hinnenkamp ER and Sotos JF: Screening tests for vanillylmandelic acid. J Pediatr 90:955–957, 1977.
Albert DM, Rubenstein RA and Scheie HG: Tumor metastasis to the eye. Part II. Clinical study of infants and children. Am J Ophthalmol 63:727–732, 1967.
Alfano JE: Ophthalmological aspects of neuroblastomatosis: A study of 53 verified cases. Trans Am Acad Ophthalmol Otolaryngol 72:830–848, 1968.
Allen RW Jr, Ogden B, Bentley FL and Jung AL: Fetal hydantoin syndrome, neuroblastoma and hemorrhagic disease in a neonate. JAMA 244:1464–1465, 1980.
Altman AC and Gross S: Progression from stage IV-S to stage IV neuroblastoma, with eventual spontaneous resolution. Am J Pediatr Hematol/Oncol 3:441–444, 1981.
Altman AJ and Baehner RL: Favorable prognosis for survival in children with coincident opso-myoelonus and neuroblastoma. Cancer 37:846–852, 1976.
Anders D, Kindermann G and Pfeifer U: Metastasizing fetal neuroblastoma with involvement of the placenta simulating fetal erythroblastosis. J Pediatr 82:50–53, 1973.
Andresen J, Madsen B and Stenskov V: Radiological and clinical evaluation of twenty neuroblastomas. Clin Radiol 32:191–198, 1981.
Angeletti PU and Levi-Montalcini R: Cytolytic effect of 6-hydroxydopamine on neuroblastoma cells. Cancer Res 30:2863–2869, 1970.
Araki T, Itai Y and Iio M: CT features of calcification in abdominal neuroblastoma. J Comp Assist Tomo 6:789–791, 1982.
Arenson EB Jr, Hutter JJ Jr, Restuccia RD and Holton CP: Neuroblastoma in father and son. JAMA 235:727–729, 1976.
Arger PH, Mulhern CB Jr, Littman PS, Meadows AT, Coleman BG and Jarrett PT: Management of solid tumors in children: Contributions of computed tomography. Am J Roentgenol 137:251–255, 1981.
Arima E, Byfield JE, Finklestein JZ and Fonkalsrud EW: An experimental model for the therapy of mouse neuroblastoma. J Pediatr Surg 8:757–762, 1973.
Armstrong EA, Harwood-Nash DCF, Ritz CR, Chuang SH, Pettersson H and Martin DJ: CT of neuroblastomas and ganglioneuromas in children. Am J Roentgenol 139:571–576, 1982.
Askin JA and Geschickter CF: Neuroblastoma of the adrenal in children. J Pediatr 7:157–178, 1935.
August CS, Serota FT, Koch PA, Burkey E, Schlesinger H, Elkins WL, Evans AE and D’Angio GJ: Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609–616, 1984.
Augusti-Tocco G and Sato G: Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Nat Acad Sei 64:311–315, 1969.
Balaban G and Gilbert F: Homogeneously staining regions in direct preparations from human neuroblastomas. Cancer Res 42:1838–1842, 1982.
Balakrishnan V and Simpson DA: Cerebellar syndromes in occult neuroblastomas. Aust Paediatr J 16:191–193, 1980.
Bale JR and Bray PF: Convulsions with an occult neural-crest tumor. New Engl J Med 301:555–556, 1979 (Letter).
Banal N, Wainstein M and Kropp KA: Congenital hydronephrosis with ipsilateral adrenal neuroblastoma: A case report. J Urol 120:354–355, 1978.
Barrett AF and Toye DKM: Sympathicoblastoma: Radiological findings in forty-three cases. Clin Radiol 14:33–42, 1963.
Bar-Ziv J and Nogrady MB: Mediastinal neuroblastoma and ganglioneuroma. Am J Roentgenol 125:380–390, 1975.
Baum ES, Gaynon P, Greenberg L, Krivit W and Hammond D: Phase II trial of cis-platin in refractory childhood cancer: Children’s cancer study group report. Cancer Treat Rep 65:815–822, 1981.
Beckerman BL and Seaver R: Congenital Horner’s syndrome and thoracic neuroblastoma. J Pediatr Ophthalmol Strab 15:24–25, 1978.
Beckwith JB and Martin RF: Observations on the histopathology of neuroblastomas. J Pediatr Surg 3:106–110, 1968.
Beckwith JB and Perrin EV: In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am J Pathol 43:1089–1104, 1963.
Belasco JB and McMillan CW: Occult neuroblastoma: Difficulties of diagnosis. Am J Dis Child 133:858–860, 1979.
Beltran G, Leiderman E, Stuckey WJ Jr, Ferran VJ and Mogabgar WJ: Metastatic ganglioneuroblastoma. Cancer 24:552–559, 1969.
Berg BO, Ablin AR, Wang W and Skoglund R: Encephalopathy associated with occult neuroblastoma. J Neurosurg 41:567–572, 1974.
Berger PE, Kuhn JP and Munschauer RW: Computed tomography and ultrasound in the diagnosis and management of neuroblastoma. Radiology 128:663–667, 1978.
Bergstrom JF and Long JM: Familial occurrence of ganglioneuromas. Tex Med 70(7):62–65, 1974.
Biedler JL, Belson L and Spengler BA: Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643–2652, 1973.
Birch JM: Personal communication.
Birch JM, Marsden HB and Swindell R: Incidence of malignant disease in childhood: A 24-year review of the Manchester children’s tumor registry data. Br J Cancer 42:215–223, 1980.
Bleyer WA, Krivit W, Chard RL Jr and Hammond D: Phase II study of VM-26 in acute leukemia, neuroblastoma and other refractory childhood malignancies: A report from the children’s cancer study group. Cancer Treat Rep 63:977–981, 1979.
Bloom SR, Polak JM and Pearse AGE: Vasoactive intestinal peptide and waterydiarrhea syndrome. Lancet 2:14–16, 1973.
Bodian M: Neuroblastoma. Arch Dis Child 38:606–619, 1963.
Bodian M: Neuroblastoma. Pediatr Clin NA 6:449–472, 1959.
Boldt DW and Reilly BJ: Computed tomography of abdominal mass lesions in children. Radiology 124:371–378, 1977.
Bonadonna G, Beretta G, Tancini G, Brambilla C, Bajetta E, De Palo GM, De Lena M, Fossati Bellani F, Gasparini M, Valagussa P and Veronesi U: Adriamycin (NSC-123127) studies at the Istituto Nazionale Tumori, Milan. Cancer Chemo Rep Part 3 6:231–245, 1975.
Bond JV: Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma. Arch Dis Child 50:691–695, 1975.
Bond JV: Familial neuroblastoma and ganglioneuroblastoma. JAMA 236:561–562, 1976 (Letter).
Bond JV: Neuroblastoma metastatic to the liver in infants. Arch Dis Child 51:879–882, 1976.
Bove KE and Mc Adams AJ: Composite ganglioneuroblastoma. Arch Pathol Lab Med 105:325–330, 1981.
Brandeis WE, Helson L, Wang Y, Good RA and Day NK: Circulating immune complexes in sera of children with neuroblastoma. J Clin Invest 62:1201–1209, 1978.
Brandt S, Carlsen N, Glenting P and Helweg-Larsen J: Encephalopathia myoclonica infantalis (Kinsbourne) and neuroblastoma in children. A report of three cases. Develop Med Child Neurol 16:286–294, 1974.
Bray PF, Wu JT and Myers GG: Reliable chemical diagnosis of neuroblastoma better than screening. New Engl J Med 295:230–231, 1976 (Letter).
Bray PF, Ziter FA, Lahey ME and Myers GG: The coincidence of neuroblastoma and acute cerebellar eneephalopathy. J Pediatr 75:983–990, 1969.
Bray PF, Ziter FA, Lahey ME and Myers GG: The coincidence of neuroblastoma and acute cerebellar eneephalopathy. Trans Am Neurol Assoc 94:106–109, 1969.
Breslow N and Mc Cann B: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098–2103, 1971.
Brewster MA and Berry DH: Dopamine-beta-hydroxylase effectors in neuroblastoma. Ann Clin Lab Sei 9:343–346, 1979.
Brewster MA and Berry DH: Serial studies of serum dopamine-beta-hydroxylase and urinary vanillylmandelic and homovanillic acid in neuroblastoma. Med Pediatr Oncol 6:93–99, 1979.
Brissaud HE and Beauvais P: Opsoclonus and neuroblastoma. New Engl J Med 280:1242, 1969 (Letter).
Brock CE and Ricketts RR: Hemoperitoneum from spontaneous rupture of neonatal neuroblastoma. Am J Dis Child 136:370–371, 1982.
Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL and Tsiatis AA: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41:4678–4686, 1981.
Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124, 1984.
Brodeur GM, Sekhon GS and Goldstein MN: Chromosomal aberrations in human neuroblastomas. Cancer 40:2256–2263, 1977.
Brown ML: Significance of the solitary lesion in pediatric bone scanning: Concise communication. J Nucl Med 24:114–115, 1983.
Camplejohn RS and Aherne WA: In vitro labelling of childhood cancers with tritiated thymidine. Br J Cancer 29:487–489, 1974.
Carli M, Bucolo C, Pannunzio MT, Ongaro G, Businaro R and Revoltella R: Fluctuation of serum complement levels in children with neuroblastoma. Cancer 43:2399–2404, 1979.
Carlsen NLT, Nielsen OH and Hertz H: Neuroblastoma. Acta Paediatr Scand 70:61–66, 1981.
Casper JT, Borella L and Sen L: Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts. Cancer Res 37:1750–1756, 1977.
Casper JT, Trent JM, Harb J, Piaskowski V, Helmsworth M, Finlan J and Von Hoff DD: Distinguishing characteristics of a new neuroblastoma cell line. Cancer Genet Cytogenet 10:177–186, 1983.
Castlberry RP, Crist WM, Cain WS, Holbrook T, Malluh A and Salter MM: Management of localized thoracic neuroblastoma. Med Pediatr Oncol 7:153–161, 1979.
Catalano PW, Newton WA Jr, Williams TE Jr, Clatworthy HW Jr and Kilman JW: Reasonable surgery for thoracic neuroblastoma in infants and children. J Thor Cardiovasc Surg 76:459–462, 1978.
Chaffey WC: Multiple sarcoma in a child. Trans Pathol Soc London 36:415–416, 1885.
Chang JHT and Prasad KN: Differentiation of mouse neuroblastoma cells in vitro and in vivo induced by cyclic adenosine monophosphate. J Pediatr Surg 11:847–856, 1976.
Chard RL Jr, Krivit W, Bleyer WA and Hammond D: Phase II study of VP-16–213 in childhood malignant disease: A children’s cancer study group report. Cancer Treat Rep 63:1755–1759, 1979.
Chatten J and Voorhess ML: Familial neuroblastoma. New Engl J Med 277:1230–1236, 1967.
Chelmicka-Szorc E and Arnason BGW: Effect of 6-hydroxydopamine on tumor growth. Cancer Res 36:2382–2384, 1976.
Chelmicka-Schorr E and Arnason BGW: Modulatory effect of the sympathetic nervous system on neuroblastoma tumor growth. Cancer Res 38:1374–1375, 1978.
Chung HS, Higgins GR, Siegel SE and Seeger RC: Abnormalities of the immune system in children with neuroblastoma related to the neoplasm and chemotherapy. J Pediatr 90:548–554, 1977.
Cochran W: Neuroblastoma (sympathicoblastoma) in northern Ireland: Review over a 10 year period. Ulster Med J 32:82–98, 1963.
Coldman AJ, Fryer CJH, Elwood JM and Sonley MJ: Neuroblastoma: Influence of age at diagnosis, stage, tumor site and sex on prognosis. Cancer 46:1896–1901, 1980.
Collin PP, Schmidt M, Bensoussan A, Blanchard H and Desjardins JG: Neurogenic tumors and VIP-induced diarrhea. J Pediatr Surg 14:525–526, 1979.
Conde E, Lafarga M, Bureo E, Baro J, Garijo J, Recio M and Zubizarreta A: Unusual ultrastructural findings in neuroblastoma. Cancer 50:1115–1121, 1982.
Cook AM, Waller S and Loken MK: Multiple “cold” areas demonstrated on bone scintigraphy in a patient with neuroblastoma. Clin Nuc Med 7:21–24, 1982.
Cooney DR, Voorhess ML, Fisher J, Brecher M, Karp MP and Jewett TC: Vasoactive intestinal peptide producing neuroblastoma. J Pediatr Surg 17:821–825, 1982.
Cozzutto C, De Bernardi B, Comelli A and Guarino M: Bone marrow biopsy in children: A study of 111 patients. Med Pediatr Oncol 6:57–64, 1979.
Culbert S, Cangir A, Jaffe N, Sullivan MP and Dicke K: Therapeutic potential of high dose phenylalanine mustard (HDP) in pediatric solid tumors. Proc Am Assoc Cancer Res 22:400, 1981 (Abstract).
Cunat JS and Fletcher BD: Cryptic cause of renal malrotation. J Can Assoc Radiol 30:242–243, 1979.
Cushing H and Wolbach SB: The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol 3:203–216, 1927.
Dalton N: Infiltrating growth in liver and suprarenal capsule. Trans Pathol Soc London 36:247–251, 1885.
D’Angio GJ and Evans AE: Cyclic, low-dose total body irradiation for metastatic neuroblastoma. Int J Rad Oncol Biol Phys 9:1961–1965, 1983.
D’Angio GJ, Evans AE and Koop CE: Special pattern of widespread neuroblastoma with a favourable prognosis, Lancet 1:1046–1049, 1971.
Dannecker G, Leidig E, Treuner J and Niethammer D: Late recurrence of neuroblastoma: A reason for prolonged follow-up? Am J Pediatr Hematol/Oncol 5:271–274, 1983.
Davidson M, Tolentino Y and Sapir S: Opsoclonus and neuroblastoma. New Engl J Med 279:948, 1968 (Letter).
De Bault LE and Millard SA: Inhibition of growth by 6-hydroxydopamine in cultured cells of neuronal and non-neuronal origin. Cancer Res 33:745–749, 1973.
De Bernardi B, Comelli A, Cozzutto C, Lamedica G, Mori PG and Massimo L: Peptichemio in advanced neuroblastoma. Cancer Treat Rep 61:811–817, 1978.
De Bernardi B, Pastore G, Carli M, Ceci A, Paolucci G, Madon E, Mancini A, Tamaro P, Rebuffi L, Colella R and Cozzutto C: Effect of peptichemio in nonlocalized neuroblastoma. Cancer 50:10–17, 1982.
De Bernardi B, Pastore G, Garaventa A, Calculli G, Carl M, Ceci A, Cordero DI, Montezemolo L, Pianca C, Romano D and Russo A: Phase II trial of amsaerine in children with advanced metastatic neuroblastoma. Cancer Treat Rep 68:1051–1052, 1984.
de Gutierrez Moyano MB, Bergada C and Becu L: Catecholamine excretion in forty children with sympathoblastoma. J Pediatr 77:239–244, 1970.
de Gutierrez Moyano MB, Bergada C and Becu L: Significance of catecholamine excretion in the follow-up of sympathoblastomas. Cancer 27:228–232, 1971.
Delalieux C, Ebinger G, Maurus R and Sliwowski H: Myoclonic encephalopathy and neuroblastoma. New Engl J Med 292:46–47, 1975 (Letter).
de la Torre JC and Surgeon JW: A methodological approach to rapid and sensitive monoamine histofluorescence using a modified glyoxylic acid technique: The SPG method. Histochemistry 49:81–93, 1976.
De Lellis RA: Formaldehyde-induced fluorescence technique for the demonstration of biogenic amines in diagnostic histopathology. Cancer 28:1704–1710, 1971.
de Lorimier AA, Bragg KU and Linden G: Neuroblastoma in childhood. Am J Dis Child 118:441–450, 1969.
Delta BG and Pinkel D: Bone marrow aspiration in children with malignant tumors. J Pediatr 64:542–546, 1964.
Dicke WK, Kingma BE, Wadman SK, de Jogh SE and Noach EL: Ganglioneuroma as a cause of chronic diarrhea. Presented at the IXth Int Cong Paediatrics, Montreal, 1959.
Dodge HF and Benner MC: Neuroblastoma of the adrenal medulla in siblings. Rocky Mountain Med J 42:35–38, 1945.
Doering EJ, Nitschke R, Haggard ME, Land VJ, Morgan SK, Starling K, Williams T and George S: Phase II study demonstrating failure of both a five-drug continuous therapy and a two-drug pulse therapy regimen in the treatment of metastatic neuroblastoma: Southwest oncology group study 822. Cancer Treat Rep 63:1383–1384, 1979.
Donohue JP, Garrett RA, Baehner RL and Thomas MH: The multiple manifestations of neuroblastoma. J Urol 111:260–264, 1974.
Dosik GM, Rodriquez V, Benjamin RS and Bodey GP: Neuroblastoma in the adult. Cancer 41:56–63, 1978.
Doub HP: Roentgen aspect of sympathetic neuroblastoma. JAMA 109:1188–1191, 1937.
Draper GJ, Heaf MM and Kinnier Wilson LM: Occurrence of childhood cancers among sibs and estimation of familial risks. J Med Genet 14:81–90, 1977.
Dyken P and Kolar O: Dancing eyes, dancing feet: Infantile polymyoclonia. Brain 91:305–320, 1968.
Ebinger G, Verheyden R and Maurus R: Thin-layer chromatography for diagnosis of secreting neuroblastoma. Eur J Pediatr 121:63–69, 1975.
Ehrenbard LT and Chaganti RSK: Cancer in the fetal hydantoin syndrome. Lancet 2:97, 1981 (Letter).
Ekert H, Ellis WM, Waters KD and Tauro GP: Autologous bone marrow rescue in the treatment of advanced tumors of childhood. Cancer 49:603–609, 1982.
Eldeeb BB, Burns S, Robinson R, Hammond EM and Mann JR: Serum dopaminebeta-hydroxylase in children with neuroblastoma. Br J Cancer 47:115–121, 1983.
Elefant E, Vojta V and Benes V: Intraspinal neuroblastoma in a newborn baby. Arch Dis Child 33:212–216, 1958.
El Shafie M, Samuel D, Klippel CH, Robinson MG and Cullen BJ: Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas. J Pediatr Surg 18:34–36, 1983.
Emery LG, Shields M, Shah NR and Gerbes A: Neuroblastoma associated with Beckwith-Wiedemann syndrome. Cancer 52:176–179, 1983.
Ericsson JL-E, Karnstrom L and Mattson B: Childhood cancer in Sweden 1958–1974. Acta Paediatr Scand 67:425–432, 1978.
Evans AE: Mitomycin C. Cancer Chemo Rep 14:1–9, 1961.
Evans AE: IV-S neuroblastoma. Med Pediatr Oncol 6:85–91, 1979.
Evans AE, Albo V, D’Angio GJ, Finklestein JZ, Leikin S, Santulli T, Weiner J and Hammond GD: Cyclophosphamide treatment of patients with localized and regional neuroblastoma. Cancer 38:655–660, 1976.
Evans AE, Albo V, D’Angio GJ, Finklestein JZ, Leikin S, Santulli T, Weiner J and Hammond GD: Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 38:661–666, 1976.
Evans AE, Baehner RL, Chard RL Jr, Leikin SL, Pang EM and Pierce M: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. Cancer Chemo Rep 58:671–676, 1974.
Evans AE, Baum E and Chard R: Do infants with stage IV-S neuroblastoma need treatment. Arch Dis Child 56:271–274, 1981.
Evans AE, Bernstein I, Finklestein J, Klemperer M, Leikin S, Weiner JM and Hammond GD: Methyl-CCNU for patients with previously treated metastatic neuroblastoma — A phase II study. Cancer Treat Rep 61:83–85, 1977.
Evans AE, Blore J, Hadley R and Tanindi S: The La Brosse spot test: A practical aid in the diagnosis of children with neuroblastoma. Pediatrics 47:913–915, 1971.
Evans AE, Brand W, de Lorimier A, Mc Creadie C, Sather H, Leikin S and Hammond D: Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide and imidazole carboxamide. Am J Clin Oncol 6:3–8, 1984.
Evans AE, Chatten J, D’Angio GJ, Gerson JM, Robinson J and Schnaufer L: A review of 17 IV-S neuroblastoma patients at the Children’s Hospital of Philadelphia. Cancer 45:833–839, 1980.
Evans AE, D’Angio GJ, De Lorimier A, Finklestein JZ, Sather H, Leikin SE and Hammond D: Improved staging criteria for localized and regional neuroblastoma. Proc Am Assoc Clin Oncol 1:172, 1982 (Abstract).
Evans AE, D’Angio GJ and Koop CE: The role of multimodal therapy in patients with local and regional neuroblastoma. J Pediatr Surg 19:77–80, 1984.
Evans AE, D’Angio GJ and Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:374–378, 1971.
Evans AE, Heyn RM, Newton WA Jr and Leikin SL: Vincristine sulfate and cyclophosphamide for children with metastatic neuroblastoma. JAMA 207:1325–1327, 1969.
Evans AE and Hummeler K: The significance of primitive cells in marrow aspirates of children with neuroblastoma. Cancer 32:906–912, 1973.
Everson TC and Cole WH: Spontaneous Regression of Cancer. WB Saunders Company, Philadelphia, 1966, pp 88–163.
Familusi JB, Samuel I, Jaiyesimi T and Aderele WI: Superior vena cava occlusion in a 12-year old girl with neuroblastoma. Clin Pediatr 16:1160, 1171–1172, 1977.
Farber S: Neuroblastoma. Am J Dis Child 60:749–751, 1940 (Abstract).
Fausa O, Fretheim B, Elgjo K, Semb LS and Gjone E: Intractable watery diarrhea, hypokalemia and achlorhydria associated with non-pancreatic retroperitoneal neurogenous tumour containing vasoactive intestinal peptide (VIP). Scand J Gastroent 8:713–717, 1973.
Faxelius G, Teger-Nilsson A-C, Wilhelmsson S and Astrom L: Disseminated intravascular coagulation and congenital neuroblastoma. Acta Paediatr Scand 64:667–670, 1975.
Feder MK and Gilbert F: Clonal evolution in a human neuroblastoma. J Nat Cancer Inst 70:1051–1056, 1983.
Feingold M, Gheradi GJ and Simons C: Familial neuroblastoma and trisomy 13. Am J Dis Child 121:451, 1971 (Letter).
Fernbach DJ, Haddy TB, Holcomb TM, Lusher J, Sutow WW and Vietti TJ: Uracil mustard (NSC-34462) therapy for children with metastatic neuroblastoma. Cancer Chemo Rep 52:287–291, 1968.
Fernbach DJ, Haddy TB, Holcomb TM, Stuckey WJ Jr, Sullivan MP and Watkins WL: L-sarcolysin (NSC-8806) therapy for children with metastatic neuroblastoma. Cancer Chemo Rep 52:293–296, 1968.
Filler RM, Traggis DG, Jaffe N and Vawter GF: Favorable outlook for children with mediastinal neuroblastoma. J Pediatr Surg 7:136–143, 1972.
Finklestein JZ, Albo V, Ertel I and Hammond D: 5-(3,3-dimethyl-l- triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children. Cancer Chemo Rep 59:351–357, 1975.
Finklestein JZ, Arima E, Byfield PE, Byfield JE and Fonkalsrud EW: Murine neuroblastoma: A model of human disease. Cancer Chemo Rep 57:405–412, 1973.
Finklestein JZ, Ekert H, Isaacs H Jr and Higgins G: Bone marrow metastases in children with solid tumors. Am J Dis Child 119:49–52, 1970.
Finklestein JZ, Hittle RE and Hammond GD: Evaluation of a high dose regimen in childhood tumors. Cancer 23:1239–1242, 1969.
Finklestein JZ, Klemperer MR, Evans A, Bernstein I, Leikin S, McCreadie S, Grosfeld J, Hittle R, Weiner J, Sather H and Hammond D: Multi-agent chemotherapy for children with metastatic neuroblastoma: A report from children’s cancer study group. Med Pediatr Oncol 6:179–188, 1979.
Finklestein JZ, Tittle K, Meshnik R and Weiner J: Unorthodox therapy for murine neuroblastoma with 6-hydroxydopamine (NSC-233898), bretylium tosylate (NSC-62164), papaverine (NSC-35443) and butyric acid (NSC-8415). Cancer Chemo Rep 59:571–574, 1975.
Finnish Cancer Registry: Cancer in Finland 1980. Cancer Society of Finland Publication No. 32. Finnish Cancer Registry, Helsinki, 1983, p 28.
Fortner J, Nicastri A and Murphy ML: Neuroblastoma: Natural history and results of treating 133 cases. Ann Surg 167:132–142, 1968.
Fox F, Davidson J and Thomas LB: Maturation of sympatheticoblastoma into ganglioneuroma. Cancer 12:108–116, 1959.
Franklin IM and Pritchard J: Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol 36:1215–1218, 1983.
Frens DB, Bray PF, Wu JT and Lahey ME: The carcinoembryonic antigen assay: Prognostic value in neural crest tumors. J Pediatr 88:591–594, 1976.
Frew RS: On carcinoma originating in the suprarenal medulla in children. Quart J Med 4:123–140, 1911.
Frye FL and Clement ED: Sympathicoblastoma in a dog. J Am Vet Med Assoc 156:900–901, 1970.
Furmanski P, Silverman DJ and Lubin M: Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature 233:413–415, 1971.
Gaffney PC, Hansman CF and Fetterman GH: Experience with smears from bone marrow in the diagnosis of neuroblastoma. Am J Clin Pathol 31:213–221, 1959.
Gaisie G, Oh KS and Young LW: Coexistant neuroblastoma and Hirschbrung’s disease — Another manifestation of the neurocristopathy? Pediatr Radiol 8:161–163, 1979.
Gasparini M, Bardare M and Fossati Bellani F: Skin tests in childhood lymphoma and neuroblastoma. Tumori 62:429–434, 1976.
Gasparini M, Fossati Bellani F, Musumeci R and Bonadonna G: Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271) and vincristine (NSC-7574). Cancer Chemo Rep 58:365–370, 1974.
Gaynon PS, Baum ES, Krivit W and Hammond D; Phase II trial of prednimustine in children with recurrent cancer: A children’s cancer study group report. Cancer Treat Rep 66:1583, 1982.
Geiser CF and Efron ML: Cystathionuria in patients with neuroblastoma or ganglioneuroblastoma. Cancer 22:856–860, 1968.
Gerson JM, Chatten J and Eisman S: Familial neuroblastoma — A follow-up. New Engl J Med 290:1487, 1974 (Letter).
Gerson JM, Schlesinger HR, Sereni P, Moorhead PS and Hummeler K: Isolation and characterization of a neuroblastoma cell line from peripheral blood in a patient with disseminated disease. Cancer 39:2508–2512, 1977.
Ghazili S: Pelvic neuroblastoma: A better prognosis. Ann Surg 179:115–118, 1974.
Gilbert F, Balaban G, Moorhead P, Bianchi D and Schlesinger H: Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Gen Cytogen 7:33–42, 1982.
Gilboa N and Campbell JR: Neuroblastoma in a newborn with Horner syndrome and respiratory distress. Am J Dis Child 130:218, 1976 (Letter).
Gitlow SE, Bertani LM, Rausen A, Gribetz D and Dziedzic SW: Diagnosis of neuroblastoma by qualitative and quantitive determination of catecholamine metabolites in urine. Cancer 25:1377–1383, 1970.
Gitlow SE, Dziedzic LB, Strauss L, Greenwood SM and Dziedzic SW: Biochemical and histologic determinants in the prognosis of neuroblastoma. Cancer 32:898–905, 1973.
Gjessing LR: Studies of functional neural tumors. I. Urinary 3-methoxy-4-hydroxyphenyl-metabolites. Scand J Clin Lab Invest 15:463–473, 1963.
Gjessing LR: Studies of functional neural tumors. II. Cystathionuria. Scand J Clin Lab Invest 15:474–478, 1963.
Gjessing LR: Studies of functional neural tumors. III. Cystathionine in the tumor tissue. Scand J Clin Lab Invest 15:479–482, 1963.
Goldman A and Malpas JS: Phase I and II study of AMSA in childhood tumours. Cancer Chemo Pharmacol 9:53–56, 1982.
Goldstein M, Freedman LS, Bohoun AC and Guerinot F: Serum dopamine-betahydroxylase activity in neuroblastoma. New Engl J Med 286:1123–1125, 1972.
Goldstein M, Joh TH and Gang H: Some aspects of the biosynthesis of catecholamines in adrenal glands and in pheochromocytoma and neuroblastoma tumors. Proc 7th Int Cong International Cong of Clinical Chemistry, Geneva/Evian, 1969, Vol 3, Hormones, Lipids and Miscellaneous, JP Felber and JJ Scheidegger (eds), Basel, S Karger, 1970, pp 78–87.
Graham JDP: Pressor amines and neuroblastoma. Nature 183:1733–1734, 1959.
Graham-Pole J, Coccia P, Lazarus HM, Weiner R, Herzig RH, Strandjord S and Gross S: High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing’s sarcoma. Am J Pediatr Hematol/Oncol 6:17–26, 1984.
Graham-Pole J, Ogg LJ, Ross CE and Cochran AJ: Sensitisation of neuroblastoma patients and related and unrelated contacts to neuroblastoma extracts. Lancet 1:1376–1379, 1976.
Graham-Pole J, Salmi T, Anton AH, Abramowsky C and Gross S: Tumor and urine catecholamines (CATs) in neurogenic tumors. Cancer 51:834–839, 1983.
Green AA, Hayes FA and Hustu HO: Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma. Cancer 48:2310–2317, 1981.
Green AA, Hustu HO, Palmer R and Pinkel D: Total-body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma. Cancer 38:2250–2257, 1976.
Green M, Cooke RE and Lattanzi W: Occurrence of chronic diarrhea in three patients with ganglioneuromas. Pediatrics 23:951–955, 1959.
Greenberg R, Rosenthal I and Falk GS: Electron microscopy of human tumors secreting catecholamines: Correlation with biochemical data. J Neuropathol Exp Neurol 28:475–500, 1969.
Greenberg RE and Gardner LI: Catecholamine metabolism in a functional neural tumor. J Clin Invest 39:1729–1736, 1960.
Greenberg RE and Gardner LI: New diagnostic test for neural tumors of infancy: Increased urinary excretion of 3-methoxy-4-hydroxymandelic acid and norepinephrine in ganglioneuroma with chronic diarrhea. Pediatrics 24:683–684, 1959 (Letter).
Griffin ME and Bolande RP: Familial neuroblastoma with regression and maturation to ganglioneurofibroma. Pediatrics 43:377–382, 1969.
Griscom NT: The roentgenology of neonatal abdominal masses. Am J Roentgenol 93:447–463, 1965.
Grosfeld JL and Baehner RL: Neuroblastoma: An analysis of 160 cases. World J Surg 4:29–39, 1980.
Grosfeld JL, Ballantine TVN and Baehner RL: Experience with “second-look” operations in pediatric solid tumors. J Pediatr Surg 13:275–280, 1978.
Grosfeld JL, Schatzlein M, Ballantine TVN, Weetman RM and Baehner RL: Metastatic neuroblastoma: Factors influencing survival. J Pediatr Surg 13:59–65, 1978.
Grosfeld JL, Sitarz A, Finklestein J and Leikin S: The effect of primary tumor resection on survival in metastatic neuroblastoma. Proc Am Assoc Cancer Res 18:308, 1977 (Abstract).
Gross RE: The Surgery of Infancy and Childhood. WB Saunders Company, Philadelphia, 1953, pp 606–625.
Gross RE, Farber S and Martin LW: Neuroblastoma sympatheticum. Pediatrics 23:1179–1191, 1959.
Grotting JC, Kassel S and Dehner LP: Nesidioblastosis and congenital neuroblastoma. Arch Pathol Lab Med 103:642–646, 1979.
Guin GH, Gilbert EF and Jones B: Incidental neuroblastoma in infants. Am J Clin Pathol 51:126–136, 1969.
Gutierrez ML, Evans EA, Rohrbaugh T, Belasco J, Lee FH and Crooke ST: Phase II evaluation of mitomycin C (MMC) in children with refractory solid tumors using the single high-intermittent dose schedule. Med Pediatr Oncol 9:405–407, 1981.
Haag MM, Soukup SW and Neely JE: Chromosome analysis of human neuroblastoma. Cancer Res 41:2995–2999, 1981.
Haber SL and Bennington JL: Maturation of congenital extra-adrenal neuroblastoma. Arch Pathol 76:121–125, 1963.
Haggard ME, Cangir A, Ragab AH, Komp D, Falletta J and Humphrey GB: Sfluorouracil in childhood solid tumors. Cancer Treat Rep 61:69–71, 1977.
Hagstrom HT: Fetal dystocia due to metastatic neuroblastoma of the liver. Am J Obstet Gynecol 19:673–676, 1930.
Haller JA Jr, Shermeta DW, Donahoo JS and White JJ: Life-threatening respiratory distress from mediastinal masses in infants. Ann Thorac Surg 19:364–370, 1975.
Haller JO, Berdon WE, Baker DH and Kassner EG: Left adrenal neuroblastoma with normal-appearing urogram. Am J Roentgenol 129:1051–1055, 1977.
Hamilton JR, Radde IC and Johnson G: Diarrhea associated with adrenal ganglioneuroma. Am J Med 44:453–463, 1968.
Hann H-WL, Evans AE, Cohen IJ and Leitmeyer JE: Biologic differences between neuroblastoma stages IV-S and IV. New Engl J Med 305:425–429, 1981.
Hann H-WL, Levy HM and Evans AE: Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 40:1411–1413, 1980.
Hansen LP, Lund HT, Fahrenkrug J and Sogaard H: Vasoactive intestinal polypeptide (VIP)-producing ganglioneuroma in a child with chronic diarrhea. Acta Paediatr Scand 69:419–424, 1980.
Hansman CF and Girdany BR: The roentgenographic findings associated with neuroblastoma. J Pediatr 51:621–633, 1957.
Hardy PC and Nesbit ME Jr: Familial neuroblastoma: Report of a kindred with a high incidence of infantile tumors. J Pediatr 80:74–77, 1972.
Hassenbusch S, Kaizer H and White JJ: Prognostic factors in neuroblastic tumors. J Pediatr Surg 11:287–297, 1976.
Hauser H: Radiosensitive neuroblastoma. Am J Roentgenol 31:234–237, 1934.
Hawfield HH and Daisley GW Jr: A report of a case of a functional adrenal ganglioneuroma. Clin Proc Child Hosp Washington DC 8:98–105, 1952.
Hayes FA, Green AA, Casper J, Cornet J and Evans WE: Clinical evaluation of sequentially scheduled cisplatin and VM-26 in neuroblastoma: Response and toxicity. Cancer 48:1715–1718, 1981.
Hayes FA, Green AA, Hustu HO and Kumar M: Surgical-pathological staging of neuroblastoma (Nb): Importance of node metastases. Proc Am Assoc Cancer Res 22:401, 1981 (Abstract).
Hayes FA, Green A, Hustu HO and Kumar M: Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatr 102:59–62, 1983.
Hayes FA, Green AA and Mauer AM: Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res 37:3766–3770, 1977.
Hayes FA and Mauer AM: Cell kinetics and chemotherapy in neuroblastoma. J Nat Cancer Inst 57:697–699, 1976.
Head DR, Kennedy PS and Goyette RE: Metastatic neuroblastoma in bone marrow aspirate smears. Am J Clin Pathol 72:1008–1011, 1979.
Heise’ MA, Miller JH, Reid BS and Siegel SE: Radionuclide bone scan in neuroblastoma. Pediatrics 71:206–209, 1983.
Hellstrom I, Hellstrom KE, Bill AH, Pierce GE and Yang JPS: Studies on cellular immunity to human neuroblastoma cells. Int J Cancer 6:172–188, 1970.
Hellstrom KE, Hellstrom I and Nepom JT: Specific blocking factors — are they important? Biochim Biophys Acta 473:121–148, 1977.
Hellstrom I, Hellstrom KE, Pierce GE and Bill AH: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Nat Acad Sci 60:1231–1238, 1968.
Hellstrom I, Hellstrom KE, Sjogren H and Warner GA: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer 7:1–16, 1971.
Helson L: Investigational chemotherapy of neuroblastoma. J Florida Med Assoc 66:284–287, 1979.
Helson L: Reactions to dinitrochlorobenzene in patients with neuroblastoma and survival. J Nat Cancer Inst 57:723–724, 1976.
Helson L, Bethune V and Schwartz MK: Clinical evaluation of the VMA test strip. Pediatrics 51:153, 1973 (Letter).
Helson L, Blasco P and Murphy ML: Familial neuroblastoma. Clin Res 17:614, 1969 (Abstract).
Helson L, Das SK and Hajdu SI: Human neuroblastoma in nude mice. Cancer Res 35:2594–2599, 1975.
Helson L and Denoix L: Four-drug sequential them otherapy for metastatic neuroblastoma. Eur J Cancer 9:883–885, 1973.
Helson L, Fleischer M, Bethune V, Murphy ML and Schwartz MK: Urinary cystathionine, catecholamine and metabolites in patients with neuroblastoma. Clin Chem 18:613–615, 1972.
Helson L, Ghavimi F, Wu C-J, Fleisher M and Schwartz MK: Carcinoembryonic antigen in children with neuroblastoma. J Nat Cancer Inst 57:725–726, 1976.
Helson L, Jereb B and Vogel R: Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma. A pilot study. Int J Rad Oncol Biol Phys 7:531–534, 1981.
Helson L, Johnson GA and Smith R: DOPA metabolism in neuroblastoma. Med Pediatr Oncol 8:317–322, 1980.
Helson L, Shou L and Tauber J: Lymphocyte transformation in children with neuroblastoma. J Nat Cancer Inst 57:721–722, 1976.
Helson L, Vanichayangkul P, Tan CC, Wollner N and Murphy ML: Combination intermittent chemotherapy for patients with disseminated neuroblastoma. Cancer Chemo Rep 56:499–503, 1972.
Hendry GMA: Cystic neuroblastoma of the adrenal gland — A potential source of error in ultrasonic diagnosis. Pediatr Radiol 12:204–206, 1982.
Hicks N, Zack M, Caldwell GG, Fernbach DJ and Falletta JM: Childhood cancer and occupational radiation exposure in parents. Cancer 53:1637–1643, 1984.
Hicsonmez G and Ozsoylu S: Diffuse infiltration of bone marrow by tumor cells. Turk J Pediatr 16:21–29, 1974.
Hill BT and Whelan RDH: Assessment of the sensitivities of cultured human neuroblastoma cells to anti-tumor drugs. Pediatr Res 15:1117–1122, 1981.
Hinterberger H and Bartholomew RJ: Catecholamines and their acidic metabolites in urine and in tumor tissue in neuroblastoma, ganglioneuroma and phaeochromocytoma. Clin Chim Acta 23:169–175, 1969.
Hinton P and Buschke F: Neuroblastoma in children, 42 cases. Radiol Clin Biol 37:19–28, 1968.
Holgerson LO, Santulli TV, Schullinger JN and Berdon WE: Neuroblastoma with intraspinal (dumbell) extension. J Pediatr Surg 18:406–411, 1983.
Hope JW, Borns PF and Berg PK: Roentgenologic manifestations of Hirschbrung’s disease in infancy. Am J Roentgenol 95:217–229, 1965.
Horn RC Jr, Koop CE and Kieswetter WB: Neuroblastoma in childhood. Lab Invest 5:106–119, 1956.
Hortnagl H, Hortnagl H, Winkler H, Asamer H, Fodisch HJ and Klima J: Storage of catecholamines in neuroblastoma and ganglioneuroma. Lab Invest 27:613–619, 1972.
Howman-Giles RB, Gilday DL and Ash JM: Radionuclide skeletal survey in neuroblastoma. Radiology 131:497–502, 1979.
Hrabovsky E and Jones B: Congenital intraspinal neuroblastoma. Am J Dis Child 133:73–75, 1979.
Hughes M, Marsden HB and Palmer MK: Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706–1711, 1974.
Hutchison R: On suprarenal sarcoma in children with metastases in the skull. Quart J Med 1:33–38, 1907.
Hyman W and Sztramski GA: Misdiagnosis of neuroblastoma. New York State J Med 55:1344–1346, 1955.
Iida Y, Nose O, Kai H, Okada A, Mori T, Lee P-K, Kakudo K and Yanaihara N: Watery diarrhea with a vasoactive intestinal peptide-producing ganglioneuroblastoma. Arch Dis Child 55:929–936, 1980.
Ikeda Y, Lister J, Bouton JM and Buyukpamukcu M: Congenital neuroblastoma, neuroblastoma in situ and the normal fetal development of the adrenal. J Pediatr Surg 16:636–644, 1981.
Imashuku S, Takada H, Sawada T and Nakamura T: Tyrosine hydroxylase activity in neuroblastoma and human adrenal gland. J Lab Clin Med 80:190–199, 1972.
Imashuku S, Takada H, Sawada T, Nakamura T and La Brosse EH: Studies on tyrosine hydroxylase in neuroblastoma, in relation to urinary levels of catecholamine metabolites. Cancer 36:450–457, 1975.
Infante PF and Newton WA Jr: Prenatal chlordane exposure and neuroblastoma. New Engl J Med 293:308, 1975 (Letter).
Iriarte PV, Hananian J and Cortner JA: Central nervous system leukemia and solid tumors of childhood. Cancer 19:1187–1194, 1966.
Isaacs H, Medalie M and Politzer WM: Noradrenaline-secreting neuroblastoma. Br Med J 1:401–404, 1959.
Ishiguro Y, Kato K, Ito T, Nagaya M, Yamada N and Sugito T: Nervous system specific enolase in serum as marker for neuroblastoma. Pediatrics 72:696–700, 1983.
Ishikawa S: Differentiation of human neuroblastoma cells in vitro — Morphological changes induced by dibutyryl cyclic AMP. Acta Pathol Jap 27:697–711, 1977.
Jacobson HM, Marcus RB Jr, Thar TL, Million RR, Graham-Pole JR and Talbert JL: Pediatric neuroblastoma: Postoperative radiation therapy using less than 2000 rad. Int J Rad Oncol Biol Phys 9:501–505, 1983.
Jaffe N: Late death from neuroblastoma. J Pediatr 82:1094, 1973 (Letter).
Jaffe N, Cassady JR, Filler RM, Petersen R and Traggis D: Heterochromia and Horner syndrome associated with cervical and mediastinal neuroblastoma. J Pediatr 87:75–77, 1975.
Jaffe R and Yunis EJ: Neuron specific enolase is useful in the differential diagnosis of childhood round cell tumors. Lab Invest 48:7p, 1983 (Abstract).
Jahadi MR, Whitcomb JG, Kini R and High RH: The association of acute cerebellar encephalopathy and neuroblastoma. Henry Ford Hosp Med J 24:87–90, 1976.
James DH: Proposed classification of neuroblastoma. J Pediatr 71:764, 1967.
James DH Jr and George P: Vincristine in children with malignant solid tumors. J Pediatr 64:534–541, 1964.
James DH Jr, Hustu HO, Wrenn EL Jr and Pinkel D: Combination chemotherapy of childhood neuroblastoma. JAMA 194:103–106, 1965.
Jansen-Goemans A and Engelhardt J: Intractable diarrhea in a boy with vasoactive intestinal peptide-producing ganglioneuroblastoma. Pediatrics 59:710–716, 1977.
Johnson AT and Halbert D: Congenital neuroblastoma presenting as hydrops fetalis. NC Med J 35:289–291, 1974.
Johnsonbaugh RE and Cahill R: Screening procedures for neuroblastoma: False-negative results. Pediatrics 56:267–270, 1975.
Jones A, Groover R and Smithson W: Acute cerebellar encephalopathy (ACE): Its natural history and relationship to neuroblastoma (NB). Proc Am Soc Clin Oncol 3:86, 1984 (Abstrct).
Jose DG and Seshadri R: Circulating immune complexes in human neuroblastoma: Direct assay and role in blocking specific cellular immunity. Int J Cancer 13:824–838, 1974.
Jose DG and Skvaril F: Serum inhibitors of cellular immunity in human neuroblastoma. IgG sublcass of blocking activity. Int J Cancer 13:173–178, 1974.
Kamalakar P, Freeman AI, Higby DJ, Wallace JH Jr and Sinks LF: Clinical responses and toxicity with cis-dichlorodiammineplatinum (II) in children. Cancer Treat Rep 61:835–839, 1977.
Kaplan LI: Sympathicoblastoma with metastases associated with the clinical picture of Cushing’s syndrome: Report of a case. Arch Neurol Psychiatr 62:696–697, 1949 (Abstract).
Kaplan SJ, Holbrook T, McDaniel HG, Buntain WL and Crist WM: Vasoactive intestinal peptide secreting tumors of childhood. Am J Dis Child 134:21–24, 1980.
Kaser H: Catecholamine producing neural tumors other than pheochromocytoma. Pharmacol Rev 18:659–665, 1966.
Kaser H and von Studnitz W: Urine of children with sympathetic tumors. Am J Dis Child 102:199–204, 1961.
Kaser H and Wagner HP: Biochemical screening for neural crest tumors in childhood. J Pediatr Surg 10:69–72, 1975.
Katcher AL: Congenital neuroblastoma of the spinal canal. J Pediatr 40:785–788, 1952.
Kaufman RA, Thrall JH, Keyes JW Jr, Brown ML and Zakem JF: False negative bone scans in neuroblastoma metastatic to the ends of long bones. Am J Roentgenol 130:131–135, 1978.
Kauten JR and,Pearson SH: Congenital intradural neuroblastoma. Child’s Brain 6:101–109, 1980.
Keating JW and Cromwell LD: Remote effects of neuroblastoma. J Roentgenol 131:299–303, 1978.
Kedar A, Glassman M, Voorhess ML, Fisher J, Allen J, Jenis E and Freeman AI: Severe hypertension in a child with ganglioneuroblastoma. Cancer 47:2077–2080, 1981.
Kemshead JT, Ritter MA, Cotmore SF and Greaves MF: Human thy-1 expression on the cell surface of neuronal and glial cells. Brain Res 236:451–461, 1982.
Kenny FM, Stavrides A, Voorhess ML and Klein R: Cushing’s syndrome associated with an adrenal neuroblastoma. Am J Dis Child 113:611–615, 1967.
Kenny PJ, Siegel MJ and Mc Alister WH: Congenital intraspinal neuroblastoma: A treatable simulant of myelodysplasia. Am J Roentgenol 138:166–167, 1982.
Keogh B, Chu TM, Williams P, Moore RH and Murphy GP: Studies and characterization of a murine neuroblastoma model. J Surg Oncol 8:449–459, 1976.
Kinast M, Levin HS, Rothner AD, Erenberg G, Wacksman J and Judge J: Cerebellar ataxia, opsoclonus and occult neural crest tumor. Am J Dis Child 134:1057–1059, 1980.
Kincaid OW, Hodgson JR and Dockerty MB: Neuroblastoma: A roentgenologic and pathologic study. Am J Roentgenol 78:420–436, 1957.
King D, Goodman J, Hawk T, Boles ET Jr and Sayers MP: Dumbell neuroblastomas in children. Arch Surg 110:888–891, 1975.
King RL, Storaasli JP and Bolande RP: Neuroblastoma: Review of twenty-eight cases and presentation of two cases with metastases and long survival. Am J Roentgenol 85:733–747, 1961.
Kinney H, Faix R and Brazy J: The fetal alcohol syndrome and neuroblastoma. Pediatrics 66:130–132, 1980.
Kinnier Wilson LM and Draper GJ: Neuroblastoma. Its natural history and prognosis: A study of 487 cases. Br Med J 3:301–307, 1974.
Kinumaki H, Takeuchi H and Ohmi K: Serum lactate dehydrogenase isoenzyme pattern in neuroblastoma. Eur J Pediatr 123:83–87, 1976.
Klebe RJ and Ruddle FH: Neuroblastoma: Cell culture analysis of a differentiating stem cell system. J Cell Biol 43:69a, 1969 (Abstract).
Klemperer MR, Ganick D, Shigeoka A, Lee H and Segel G: Attempted treatment of a child with metastatic neuroblastoma employing syngeneic marrow transplantation. Transplantation 21:161–164, 1976.
Klingman WO and Hodges RG: Acute ataxia of unknown origin in children. J Pediatr 24:536–543, 1944.
Knight JA, Fronk S and Haymond RE: Chemical basis and specificity of chemical screening tests for urinary vanilmandelic acid. Clin Chem 21:130–133, 1975.
Knudson AG Jr and Amromin GD: Neuroblastoma and ganglioneuroma in a child with multiple neurofibromatosis — Implications for the mutational origin of neuroblastoma. Cancer 19:1032–1037, 1966.
Knudson AG Jr and Meadows AT: Regression of neuroblastoma IV-S: A genetic hypothesis. New Engl J Med 302:1254–1256, 1980.
Knudson AG Jr and Strong LC: Mutation and cancer: Neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514–532, 1972.
Kogut MD and Donnell GN: Cushing’s syndrome in association with renal ganglioneuroblastoma. Pediatrics 28:566–577, 1961.
Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F and Alt FW: Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35:359–367, 1983.
Koivikko M and Poyhonen TH: Occult neuroblastoma presenting with cerebellar symptoms: Results of computed tomography. Acta Paediatr Scand 69:255–256, 1980.
Komp DM, Land VJ, Nitschke R, Cangir A and Dyment P: 5-(3,3-bis(2-chloroethyl)1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy. Cancer Chemo Rep 59:371–376, 1975.
Konrad PN, Singher LJ and Neerhout RC: Late death from neuroblastoma. J Pediatr 82:80–82, 1973.
Kontras SB: Urinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastoma. Cancer 15:978–986, 1962.
Kontras SB and Newton WA Jr: Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma. Preliminary report. Cancer Chemo Rep 12:39–50, 1961.
Koop CE and Hernandez JR: Neuroblastoma: Experience with 100 cases in children. Surgery 56:726–733, 1964.
Koop CE, Kiesewetter WB and Horn RC: Neuroblastoma in childhood. Surgery 38:272–278, 1955.
Koop CE, Kiesewetter WB and Horn RC: Neuroblastoma in childhood. Pediatrics 16:652–657, 1955.
Koppersmith SL, Powers JM and Hennigar GR: Angiomatoid neuroblastoma with cytoplasmic glycogen. Cancer 45:553–560, 1980.
Korobkin M, Clark RE and Palubinskas AJ: Occult neuroblastoma and acute cerebellar ataxia in childhood. Radiology 102:151–152, 1972.
Kretschmer CS, Frantz CN, Rosen EM, Cassady JR, Levey R and Sallan SE: Improved prognosis for infants with stage IV neuroblastoma. J Clin Oncol 2:799–803, 1984.
Krieger JN, Ghasko SB and Keuhnelian JG: Paratesticular neuroblastoma associated with subependymal giant cell astrocytoma. J Urol 124:736–738, 1980.
Krivit W and Bentley HP Jr: Use of 5-fluorouracil in the management of advanced malignancies in childhood. Am J Dis Child 100:217–227, 1960.
Kumar APM, Wrenn EJ Jr, Fleming ID, Hustu HO, Pratt CB and Pinkel D: Preoperative therapy for unresectable malignant tumors in children. J Pediatr Surg 10:657–669, 1975.
Kumar S, Taylor G, Steward JK, Waghe MA and Pearson D: Cellular immunity in Wilms’ tumor and neuroblastoma. Int J Cancer 10:36–43, 1972.
Kun LE, Casper JT, Kline RW and Piaskowski VD: Fractionated total body irradiation for metastatic neuroblastoma. Int J Rad Oncol Biol Phys 7:1599–1602, 1981.
Kwee WS, Hausman R, van der Harten JJ, de Waal FC and Schreuder CH: Neuroblastoma with a fulminant clinical course caused by tumor embolism. Eur J Pediatr 132:61–66, 1979.
Labotka RJ and Morgan ER: Myelofibrosis in neuroblastoma. Med Pediatr Oncol 10:21–26, 1982.
La Brosse EH: 3-methoxy-4-hydroxyphenylglycol in neuroblastoma. J Pediatr Surg 3:148–149, 1968.
La Brosse EH: Biochemical diagnosis of neuroblastoma: Use of a urine spot test. Proc Am Assoc Cancer Res 9:39, 1968 (Abstract).
La Brosse EH, Comoy E, Bohuon C, Zucker J-M and Schweisguth O: Catecholamine metabolism in neuroblastoma. J Nat Cancer Inst 57:633–638, 1976.
La Brosse EH, Con C, Zucker J-M, Comoy E, Bohoun C, Lemerle J and Schweisguth O: Urinary excretion of 3-methoxy-4-hydroxymandehc acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 40:1995–2001, 1980.
Langman MJS: Treatment of neuroblastoma with vitamin B12. Arch Dis Child 45:385–387, 1970.
Latchaw RE, L’Heureux PR, Young G and Priest JR: Neuroblastoma presenting as central nervous system disease. Am J Neuroradiol 3:623–630, 1982.
Lauder I and Aherne W: The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 26:321–330, 1972
Laug WE, Siegel SE, Shaw KNF, Landing B, Baptista J and Gutenstein M: Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62:77–83, 1978.
Lazarus HM, Herzig RH, Graham-Pole J, Wolff SN, Phillips GL, Strandjord S, Hurd D, Forman W, Gordon EM, Coccia P, Gross S and Herzig GP: Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol 1:359–367, 1983.
Leape LL, Lowman JT and Loveland GC: Multifocal nondisseminated neuroblastoma. J Pediatr 92:75–77, 1978.
Lebouef G, Eberlein WR, Steiker DD and Bongiovanni M: Functioning ganglioneuroma, celiac syndrome and renal acidosis. Am J Dis Chid 102:693–695, 1961 (Abstrct).
Lee CM: The surgical significance of tumors in identical twins. Am Surg 19:803–811, 1953.
Leikin S, Bernstein I, Evans A, Finklestein J, Hittle R and Klemperer M: Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma. Cancer Chemo Rep 59:1015–1018, 1975.
Leonard AS, Roback SA, Nesbit ME Jr and Freier E: The VMA test strip: A new tool for mass screening, diagnosis and management of catecholamine-secreting tumors. J Pediatr Surg 7:528–531, 1972.
Leonidas JC, Brill CB and Aron AM: Neuroblastoma presenting with myoclonic encephalopathy. Radiology 102:87–88, 1972.
Liebner EJ and Rosenthal IM: Serial catecholamines in the radiation management of children with neuroblastoma. Cancer 32:623–633, 1973.
Lingley JF, Sagerman RH, Santulli TV and Wolff JA: Neuroblastoma. New Engl J Med 277:1227–1230, 1967.
Look AT, Hayes FA, Nitschke R, McWilliams NB and Green AA: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. New Engl J Med 311:231–235, 1984.
Lopez R, Karakousis C and Rao U: Treatment of adult neuroblastoma. Cancer 45:840–844, 1980.
Luse SA: Synaptic structures occurring in a neuroblastoma. Arch Neurol 11:185–190, 1964.
Lyon GM: S-adenosylmethionine in a neuroblastoma. Pediatr Res 5:360–365, 1971.
Mackay B, Luna MA and Butler JJ: Adult neuroblastoma. Cancer 37:1334–1351, 1976.
Mackay B, Masse SR, King OY and Butler JJ: Diagnosis of neuroblastoma by electron microscopy of bone marrow aspirates. Pediatrics 56:1045–1049, 1975.
Mac Millan RW, Blanc WB and Santulli TV: Maturation of neuroblastoma to ganglioneuroma in lymph nodes. J Pediatr Surg 11:461–462, 1976.
Makinen J: Microscopic patterns as a guide to prognosis of neuroblastoma in childhood. Cancer 29:1637–1646, 1972.
Malmstrom-Groth A: Cerebellar encephalopathy and neuroblastoma. Eur Neurol 7:95–100, 1972.
Malpas JS, Kemshead JT, Pritchard J and Greaves MF: Variability in surface antigen expression on neuroblastoma cells as revealed by monoclonal antibodies. IN. Pediatric Oncology. C Raybaud, R Clement, G Lebrueil and JL Bernard (eds), Excerpta Medica, Amsterdam, 1982, pp 90–94.
Mancini AF, Rosito P, Faldella G, Serra L, Vallicelli R, Vecchi V, Vivarelli F and Paolucci G: Neuroblastoma in a pair of identical twins. Med Pediatr Oncol 10:45–51, 1982.
Mann CM, Leape LL and Holder TM: Neonatal urinary ascites: A report of 2 cases of unusual etiology and a review of the literature. J Urol 111:124–128, 1974.
Marks J: Chromosomal characteristics of neurogenic tumors in children. Acta Cytol 14:510–518, 1970.
Martin ES and Griffith JF: Myoclonic encephalopathy and neuroblastoma. Am J Dis Child 122:257–258, 1971.
Martin RF and Beckwith JB: Lymphoid infiltrates in neuroblastomas, their occurrence and prognostic significance. J Pediatr Surg 3:161–163, 1968.
Mason GA, Hart-Mercer J, Millar EJ, Strang LB and Wynne NA: Adrenaline secreting neuroblastoma in an infant. Lancet 2:322–325, 1957.
Maurus R and Otten J: Biologic markers in neuroblastoma. IN. Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I. G Bonadonna, G Mathe, SE Salmon (eds), Springer-Verlag, Berlin, 1979 pp 78–84.
Mc Alack RF: Normal HLA phenotypes and neo-HLA-like antigens on cultured human neuroblastoma. Trans Proc 12:107–113, 1980.
Mc Crae D and Shaw A: Ganglioneuroma, heterochromia iridis and Horner’s syndrome. J Pediatr Surg 14:612–614, 1979.
Mc Donald P and Hiller HG: Angiography in abdominal tumours in childhood with particular reference to neuroblastoma and Wilms’ tumour. Clin Radiol 19:1–18, 1968.
Mc Guire WA, Simmons D, Grosfeld JL and Baehner RL: Stage II neuroblastomadoes adjuvant irradiation contribute to cure? Med Pediatr Oncol 13:117–121, 1985.
Mc Kendrick T and Edwards RWH: The excretion of 4-hydroxy-3-methoxy-mandelic acid by children. Arch Dis Child 40:418–425, 1965.
Mc Latchie GR and Young DG: Presenting features of thoracic neuroblastoma. Arch Dis Child 55:958–962, 1980.
Mc Millan CW, Gaundry CL Jr and Holemans R: Coagulation defects and metastatic neuroblastoma. J Pediatr 72:347–350, 1968.
Mc Whirter WR: Personal communication.
Mc Whirter WR and Bacon JE: Incidence of childhood tumors in Queensland. Br J Cancer 44:637–642, 1981.
Meadows AT and Knudson AG Jr: Heterochromia and neuroblastoma. J Pediatr 88:168, 1976 (Letter).
Mendelsohn G, Eggleston JC, Olson JL, Said SI and Baylin SB: Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors. Lab Invest 41:144–149, 1979.
Merino MJ and Livolsi VA: Small cell malignant tumors of childhood: Clinically presenting as inflammatory bowel disease. Conn Med 43:621–624, 1979.
Miller RW, Fraumeni JF Jr and Hill JA: Neuroblastoma: Epidemiologie approach to its origin. Am J Dis Child 115:253–261, 1968.
Misugi K, Misugi N and Newton WA Jr: Fine structural study of neuroblastoma, ganglioneuroblastoma and pheochromocytoma. Arch Pathol 86:160–170, 1968.
Mitchell CH, Sinatra FR, Crast FW, Griffin R and Sunshine P: Intractable watery diarrhea, ganglioneuroblastoma and vasoactive intestinal peptide. J Pediatr 89:593–595, 1976.
Moe PG and Nellhaus G: Infantile polymyoclonia-opsoclonus syndrome and neural crest tumors. Neurology 20:756–764, 1970.
Molofsky WJ and Chutorian AM: Nonsurgical treatment of intraspinal neuroblastoma. Neurology 31:1170–1173, 1981.
Moore N: Sarcoma of skeleton in a child. Trans Pathol Soc London 36:393–395, 1885.
Moorhead PS and Evans AE: Chromosomal findings in patients with neuroblastoma. IN. Advances in Neuroblastoma Research. AE Evans (ed), Raven Press, New York, 1980, pp 109–118.
Mori PG, Comelli A, Pasino M, Correra A and Massimo L: Peptichemio in children with neoplastic disease. An Esp Pediatr 76 (Suppl 9):76–83, 1976.
Morrell A, Kaser H, Scherz R and Skvaril F: Uncommon GM phenotypes in sera from neuroblastoma patients. J Immunol 118:1083–1085, 1977.
Morrison LJA, Campbell AM, Cochran AJ, Willoughby MLN and Baird GM: Tumor-directed immunity in neuroblastoma patients and their related and unrelated contacts. Am J Pediatr Hematol/Oncol 3:353–361, 1981.
Moschos A and Anagnostakis D: Congenital neuroblastoma with paraplegia. Helm Paediatr Acta 30:521–523, 1975.
Moss TJ and Kaplan L: Association of hydrops fetalis with congenital neuroblastoma. Am J Obstet Gynecol 132:905–906, 1978.
Moulton JE: Tumors in Domestic Animals. University of California Press, Berkeley, 1961 p 217.
Murphy GP, Williams P and Keogh B: Chemotherapy of a murine neuroblastoma model. J Surg Oncol 7:521–524, 1975.
Murthy TVM, Irving IM and Lister J: Massive adrenal hemorrhage in neonatal neuroblastoma. J Pediatr Surg 13:31–34, 1978.
Myers DD, Meier H, Huebner RJ, Vernon L and Walker J: Cell-free transmission of mouse neuroblastoma. Nature 234:100, 1971.
Nakayama I, Tsuda N, Muta H, Fujii H, Tsuji K, Matsuo T and Takahara O: Fine structural comparison of Ewing’s sarcoma with neuroblastoma. Acta Pathol Jap 25:251–268, 1975.
Necheles TF, Rausen AR, Kung FH and Pochedly C: Immunochemotherapy in advanced neuroblastoma. Cancer 41:1282–1288, 1978.
Nelson P, Ruffner W and Nirenberg M: Neuronal tumor cells with excitable membranes grown in vitro. Proc Nat Acad Sci 64:1004–1010, 1969.
Nevin NC, Dodge JA and Allen IV: Two cases of trisomy D associated with adrenal tumours. J Med Genet 9:119–122, 1972.
Nickerson BG and Hutter JJ Jr: Opsomyoclonus and neuroblastoma. Clin Pediatr 18:446–448, 1979.
Ninane J, Pritchard J and Malpas JS: Chemotherapy of advanced neuroblastoma: Does adriamycin contribute. Arch Dis Child 56:544–548, 1981.
Ninane J, Pritchard J, Morris-Jones PH, Mann JR and Malpas JS: Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438–442, 1982.
Nitschke R, Cangir A, Crist W and Berry DH: Intensive chemotherapy for metastatic neuroblastoma: A southwest oncology group study. Med Pediatr Oncol 8:281–288, 1980.
Nitschke R, Fagundo R, Berry DH and Falletta JM: Weekly administration of cisdichlorodiammineplatinum (II) in childhood solid tumors: A southwest oncology group study. Cancer Treat Rep 63:497–499, 1979.
Nitschke R, Starling K, Lui VKS and Pullen J: Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: A southwest oncology group study. Cancer Treat Rep 65:1105–1108, 1981.
Normann T, Havnen J and Mjolnerod O: Cushing’s syndrome in an infant associated with neuroblastoma in two ectopic adrenal glands. J Pediatr Surg 6:169–175, 1971.
Oberkircher OJ, Staubitz WJ and Parmenter FJ: A clinical study of neuroblastoma. J Pediatr 43:177–189, 1953.
Odelstad L, Pahlman S, Lackgren G, Larsson E, Grotte G and Nilsson K: Neuron specific enolase: A marker for differential diagnosis of neuroblastoma and Wilms’ tumor. J Pediatr Surg 17:381–385, 1982.
Olmstead JB, Carlson K, Klebe R, Ruddle F and Rosenbaum J: Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc Nat Acad Sci 65:129–136, 1970.
Ong M and Dupont CL: The La Brosse spot test revisited. J Pediatr 86:238–240, 1975.
Otten J and Maurus R: Clinical trial of peptichemio in solid tumors of childhood. Cancer Treat Rep 62:1015–1019, 1978.
Pack GT, Horning ED and Ariel IM: Neuroblastoma (Sympathicoblastoma). J Neuropathol Exp Neurol 11:235–256, 1952.
Page LB and Jacoby GA: Catecholamine metabolism and storage granules in pheochromocytoma and neuroblastoma. Medicine 43:379–386, 1964.
Parker RW: Diffuse (?) sarcoma of liver, probably congenital. Trans Pathol Soc London 31:290–293, 1880.
Parry TE: Two cases of neuroblastoma with marrow findings mimicking acute leukemia. Arch Dis Child 49:497, 1974 (Abstract).
Pastore G, De Bernardi B, Carli M, Acquaviva A, Cordero di Montezemolo L, Loiacono G and Tamaro P: Peptichemio in neuroblastoma at relapse. Med Pediatr Oncol 12:162–165, 1984.
Pastore G, Magnani C, Zanetti R and Terracini B: Incidence of cancer in children in the province of Torino, Italy 1967–1978. Eur J Cancer 17:1337–1341, 1981.
Pegelow CH, Ebbin AJ, Powars D and Towner JW: Familial neuroblastoma. J Pediatr 87:763–765, 1975.
Pendergrass TW and Hanson JW: Fetal hydantoin syndrome and neuroblastoma. Lancet 2:150, 1976 (Letter).
Pepper W: A study of congenital sarcoma of the liver and suprarenal. Am J Med Sei 121:287–299, 1901.
Pereira F, Crist W and Mc Kaig S: Neuroblastoma “leukemia” — A rarity? Clin Pediatr 17:701–702, 1978.
Perez CA, Vietti T, Ackerman LV, Eagleton MD and Powers WE: Tumors of the sympathetic nervous system in children. Radiology 88:750–760, 1967.
Pesehel RE, Chen M and-Seashore J: The treatment of massive hepatomegaly in stage IV-S neuroblastoma. Int J Rad Oncol Biol Phys 7:549–553, 1981.
Phillips R: Neuroblastoma. Ann Roy College Surg Engl 12:29–48, 1953.
Pinkel D: Actinomycin D in childhood cancer. Pediatrics 23:342–347, 1959.
Pinkel D: Chlorambucil in childhood cancer. Cancer 14:36–41, 1961.
Pinkel D: Cyclophosphamide in children with cancer. Cancer 15:42–49, 1962.
Pinkel D, Pratt C, Holton C, James D Jr, Wrenn E Jr and Hustu HO: Survival of children with neuroblastoma treated with combination chemotherapy. J Pediatr 73:928–931, 1968.
Plochl E, Kaser H and Klein H: Excretion of catecholamines in relatives of patients with familial neuroblastoma. Cancer Res 36:10–12, 1976.
Poore TN, Dockerty MB, Kennedy RLJ and Walters W: Abdominal neuroblastomas. Surg Clin NA 31:1121–1141, 1951.
Prasad KN: Differentiation of neuroblastoma cells induced in culture by 6thioguanine. Int J Cancer 12:631–636, 1973.
Prasad KN and Hsie AW: Morphologic differentiation of mouse neuroblastoma cells induced in vitro by dibutyryl adenosine 3’,5’ cyclic monophosphate. Nature 233:141–142, 1971.
Prasad KN and Kumar S: Role of cyclic AMP in differentiation of human neuroblastoma cells in culture. Cancer 36:1338–1343, 1975.
Prasad KN, Mandai B and Kumar S: Human neuroblastoma cell cultur3: Effect of 5-bromodeoxyuridine on morphological differentiation and levels of neural enzymes. Proc Soc Exp Biol Med 144:38–42, 1973.
Prasad KN and Sheppard JR: Inhibitors of cyclic-nucleotide phosphodiesterase induce morophological differentiation of mouse neuroblastoma cell culture. Exp Cell Res 73:436–440, 1972.
Prasad KN, Zambernard J, Lasher R and Van Woert MH: Transmission of mouse neuroblastoma by a cell-free extract. Nature 228:997–999, 1970.
Pratt CB, Etcubanas E, Thompson E, Hayes FA, Champion JE and Crom DB: Mitoxantrone (dihydroxy anthracenedione, DHAD) — Phase II study in pediatric patients. Proc Am Assoc Cancer Res 23:122, 1982 (Abstract).
Pratt CB, Hayes A, Green AA, Evans WE, Senzer N, Howarth CB, Ransom JL and Crom W: Pharmacoldnetic evaluation of cis-platin in children with malignant solid tumors: A phase II study. Cancer Treat Rep 65:1021–1026, 1981.
Pratt CB, Roberts D, Shanks E and Warmath EL: Response, toxicity and pharmacokinetics of high-dose methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue for children with osteosarcoma and other malignant tumors. Cancer Chemo Rep Part 36:13–18, 1975.
Pratt CB and Shanks EC: Doxorubicin in treatment of malignant solid tumors in children. Am J Dis Child 127:534–536, 1974.
Pratt CB and Wang JJ: Acetylenic carbamate in childhood cancer. Cancer 27:1094–1098, 1971.
Priebe CJ and Clatworthy HW Jr: Neuroblastoma. Arch Surg 95:538–545, 1967.
Pritchard J, Mc Elwain TJ and Graham-Pole J: High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86–94, 1982.
Punt J, Pritchard J, Pincott JR and Kill K: Neuroblastoma: A review of 21 cases presenting with spinal cord compression. Cancer 45:3095–3101, 1980.
Quinn JJ, Altman AJ and Frantz CN: Serum lactate dehydrogenase, an indicator of tumor activity in neuroblastoma. J Pediatr 97:89–91, 1980.
Raaf JH, Cangir A and Luna M: Induction of neuroblastoma maturation by a new chemotherapy protocol. Med Pediatr Oncol 10:275–282, 1982.
Ragab AH, Sutow WW, Komp DM, Starling KA, Lyon GM Jr and George S: Adriamycin in the treatment of childhood solid tumors. Cancer 36:1567–1571, 1975.
Rajnherc JR, van Gennip AH, Abeling NGGM, van der Zee JM and Voute PA: Cystathionuria in patients with neuroblastoma. Med Qediatr Oncol 12:81–84, 1984.
Ramilo J and Harris VJ: Neuroblastoma in a child with the hydantoin and fetal alcohol syndrome. The radiographic features. Br J Radiol 52:993–995, 1979.
Rangecroft L, Lauder I and Wagget J: Spontaneous maturation of stage IV-S neuroblastoma. Arch Dis Child 52:815–817, 1978.
Raney RB Jr, Lyon GM Jr and Porter FS: Neuroblastoma simulating acute leukemia. J Pediatr 89:433–435, 1976.
Rath R and Touloukian RJ: Infarction of a mediastinal neuroblastoma with hemorrhagic pleural effusion. Ann Thorac Surg 10:552–555, 1970.
Reiquam CW, Beatty EC Jr and Allen RP: Neuroblastomas in infancy and childhood. Am J Dis Child 91:588–592, 1956.
Reynolds CP, German DC, Weinberg AG and Smith RG: Catecholamine fluorescence and tissue culture morphology. Am J Clin Pathol 75:275–282, 1981.
Reynolds CP, Smith RG and Frenkel EP: The diagnostic dilemma of the “small round cell neoplasm”. Cancer 48:2088–2094, 1981.
Reynoso G, Chu TM, Holyoke D, Cohen E, Nemoto T, Wang J-J, Chuang J, Guinan P and Murphy GP: Carcinoembryonic antigen in patients with different cancers. JAMA 220:361–365, 1972.
Richards MJS, Joo P and Gilbert EF: The rare problem of late recurrence in neuroblastoma. Cancer 38:1847–1852, 1976.
Rivera G, Avery T and Pratt C: 4’–demethylepipodophyllotoxin 9– (4,6–0–2– thenylidene–beta–D–glucopyranoside) (NSC–122819; VM–26) and 4’–demethylepipodophyllotoxin 9– (4,6–0–ethylidene–beta–D–glucopyranoside) (NSC–141540; VP–16–213) in childhood cancer: Preliminary observations. Cancer Chemo Rep 59:743–749, 1975.
Rivera G, Green A, Hayes A, Avery T and Pratt C: Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma. Cancer Treat Rep 61:1243–1248, 1977.
Roberts KB and Freeman JM: Cerebellar ataxia and “occult neuroblastoma” without opsoclonus. Pediatrics 56:464–465, 1975.
Rockson SG, Stone RA, Odere F and Gunnells JC: Plasma dopamine-betahydroxylase in the diagnosis of neuroblastoma. Cancer 37:386–389, 1976.
Romansky SG, Crocker DW and Shaw KNF: Ultrastructural studies of neuroblastoma. Cancer 42:2392–2398, 1978.
Rosanda C, De Bernardi B, Pasino M, Bisogni MC, Maggio A, Haupt R, Tonini GP and Ponzoni M: Immune evaluation of 50 children with neuroblastoma at onset. Med Pediatr Oncol 10:321–330, 1982.
Rosen EM, Cassady JR, Kretschmar C, Frantz CN, Levey R and Sallan SE: Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260–263, 1984.
Rosen EM, Cassady JR, Frantz CN, Kretschmar C, Levey R and Sallan SE: Neuroblastoma: The joint center for radiation therapy/Dana-Farber cancer institute/Children’s hospital experience. J Clin Oncol 2:719–732, 1984.
Rosenstein BJ and Engelman K: Diarrhea in a child with a catecholamine secreting ganglioneuroma. J Pediatr 63:217–226, 1963.
Rothner AD: Congenital “dumbell” neuroblastoma with paraplegia. Clin Pediatr 10:235–236, 1971.
Ryan J, Barker PE, Shimizu K, Wigler M and Ruddale FH: Chromosomal assignment of a family of human oncogenes. Proc Nat Acad Sci 80:4460–4463, 1983.
Said SI and Faloona GR: Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. New Engl J Med 293:155–160, 1975.
Saito S, Tsuchida Y and Yokomori K: Biological activities of dumb-bell type neuroblastoma in childhood. Z Kinderchir 25:2–8, 1978.
Samuels LD, Newton WA Jr and Heyn R: Daunorubicin therapy in advanced neuroblastoma. Cancer 27:831–834, 1971.
Sandok BA and Kranz H: Opsoclonus as the initial manifestation of occult neuroblastoma. Arch Ophthalmol 86:235–236, 1971.
Savino PJ and Glaser JS: Opsoclonus. Br J Ophthalmol 59:696–698, 1975.
Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M and Kusunoki T: Neuroblastoma. Mass screening for early detection and its prognosis. Cancer 53:2731–2735, 1984.
Sawada T, Nakata T, Takasugi N, Maeda K, Hanawa Y, Shimizu K, Hiriyama M, Takeda T, Mori T, Koide R, Tsunoda A, Nagahara N and Yamamoto K: Mass screening for neuroblastoma in infants in Japan. Lancet 2:271–273, 1984.
Sawada T, Todo S, Fujita K, Iino S, Imashuku S and Kusunoki T: Mass screening of neuroblastoma in infancy. Am J Dis Child 136:710–712, 1982.
Sawitsky A: Vincristine and cyclophosphamide therapy in generalized neuroblastoma. Am J Dis Child 119:308–313, 1970.
Sawitsky A and Desposito F: A survey of American experience with vitamin B12 therapy of neuroblastoma. J Pediatr 67:99–103, 1965.
Schiebel E, Rechnitzer C, Fahrenkrug J and Hertz H: Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours. Acta Paediatr Scand 71:721–725, 1982.
Schlesinger HR, Gerson JM, Moorhead PS, Maguire H and Hummeler K: Establishment and characterization of human neuroblastoma cell lines. Cancer Res 36:3094–3100, 1976.
Schlesinger HR, Rorke L, Jamieson R and Hummeler K: Neuronal properties of neuroectodermal tumors in vitro. Cancer Res 41:2573–2575, 1981.
Schnaufer L and Koop CE: Silastic abdominal patch for temporary hepatomegaly in stage IV-S neuroblastoma. J Pediatr Surg 10:73–75, 1975.
Schoni M and Kaser H: Plasma dopamine-beta-hydroxylase in neuroblastoma. Br J Cancer 49:107–108, 1984.
Schubert D, Humphreys S, Baroni C and Cohn M: In vitro differentiation of a mouse neuroblastoma. Proc Nat Acad Sci 64:316–323, 1969.
Schubert D and Jacob F: 5-bromodeoxyuridine-induced differentiation of a neuroblastoma. Proc Nat Acad Sci 67:247–254, 1970.
Schuler D, Koos R, Krauze I and Peter A: Paraneoplastic syndrome in childhood. Acta Paediatr Acad Sci Hung 18:31–40, 1977.
Schuman AJ, Alario AJ and Pitel PA: Occult ganglioneuroma with diarrhea: Localization by venous catecholamines. Med Pediatr Oncol 12:93–96, 1984.
Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M and Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245–248, 1983.
Schwab M, Varmus HE, Bishop JM, Grzeschik H-K, Naylor SL, Sakaguchi AY, Brodeur G and Trent J: Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308:288–291, 1984.
Schwartz AD, Dadash-Zadeh M, Lee H and Swaney JJ: Spontaneous regression of disseminated neuroblastoma. J Pediatr 85:760–763, 1974.
Schweisguth O: Late relapses in neuroblastomas. IN. Pediatric Oncology. C Raybaud, R Clement, G Lebrueil and JL Bernard (eds), Excerpta Medica, Amsterdam, 1982, pp 70–75.
Schweisguth O: Neuroblastoma. IN. Cancer in Childhood. JO Godden (ed), Plenum Press, New York, 1972, pp 171–178.
Scott JP and Morgan E: Coagulopathy of disseminated neuroblastoma. J Pediatr 103:219–222, 1983.
Seeds NW, Gilman AG, Amano T and Nirenberg MW: Regulation of axon formation by clonal lines of a neural tumor. Proc Nat Acad Sci 66:160–167, 1970.
Seeger RC, Danon YL, Rayner SA and Hoover F: Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 128:983–989, 1982.
Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB and Benedict WF: Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res 37:1364–1371, 1977.
Seeler RA, Israel JN, Royal JE, Kaye CI, Rao S and Abulaban M: Ganglioneuroblastoma and fetal hydantoin-alcohol syndromes. Pediatrics 63:524–527, 1979.
Selawry OS, Holland JF and Wolman IJ: Effect of vincristine (NSC-67574) on malignant solid tumors in children. Cancer Chemo Rep 52:497–500, 1968.
Senelick RC, Bray PF, Lahey ME, VanDyk HJL and Johnson DG: Neuroblastoma and myoclonic encephalopathy: Two cases and a review of the literature. J Pediatr Surg 8:623–632, 1973.
Shanklin DR and Sotelo-Avila C: In situ tumors in fetuses, newborns and young infants. Biol Neonate 14:283–316, 1969.
Shaw RK, Moore EW, Mueller PS, Frei E III and Watkin DM: The effect of actinomycin D on childhood neoplasms. Am J Dis Child 99:628–635, 1960.
Sheffler BA, Repman MA and Schengrund C-L: Development of a neonatal and metastatic murine neuroblastoma model. Cancer Res 39:711–713, 1979.
Shende A, Wind ES and Lanzkowsky P: Intrarenal neuroblastoma mimicking Wilms’ tumor. New York State J Med 79:93, 1979.
Sherman RS and Learning R: The roentgen findings in neuroblastoma. Radiology 60:837–849, 1953
Sherman S and Roizen N: Fetal hydantoin syndrome and neuroblastoma. Lancet 2:517, 1976 (Letter).
Shimada H: Transmission and scanning electron microscopic studies on the tumors of neuroblastoma group. Acta Pathol Jap 32:415–426, 1982.
Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, Marsden HB and Misuigi K: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Nat Cancer Inst 73:405–416, 1984.
Shimizu K, Goldfarb M, Perucho M and Wigler M: Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Nat Acad Sci 80:383–387, 1983.
Shuangshoti S and Ekaraphanich S: Congenital neuroblastoma and hyperplasia of islets of Langerhans in an infant. Clin Pediatr 11:241–243, 1072.
Siegel MJ, Balfe DM, Mc Clennon BL and Levitt RG: Clinical utility of CT in pediatric retroperitoneal disease: 5 year experience. Am J Roentgenol 138:1011–1017, 1982.
Siegel MJ and Sagel SS: Computed tomography as a supplement to urography in the evaluation Of suspected neuroblastoma. Radiology 142:435–438, 1982.
Simon J and Albert LT: Two cases of neuroblastomas in dogs. J Am Vet Med Assoc 136:210–214, 1960.
Simone JV, Cassady JR and Filler RM: Cancers of childhood. IN. Cancer. Principles and Practice of Oncology. VT De Vita Jr, S Hellman and SA Rosen (eds). JB Lippincott Company, Philadelphia, 1982, pp 1275–1283.
Sindhu S and Anderson CM: Ganglioneuroma as a cause of diarrhoea and failure to thrive. Austr Paediatr J 1:56–60, 1965.
Sinniah D, Choo M and Somasundram K: Neuroblastoma in Malaysian children. Med J Malayasia 34:149–152, 1979.
Sinniah D, Lin HP, Kwan PW and Somasundram K: Stage IV-S neuroblastoma. A review from the University Hosital, Kuala Lumpur, Singapore Med J 22:254–258, 1981.
Sitarz AL, Santulli TV, Wigger HJ and Berdon WE: Complete maturation of neuroblastoma with bone metastases in documented stages. J Pediatr Surg 10:533–536, 1975.
Smellie JM and Sandler M: Secreting intrathoracic ganglioneuroma. Proc Roy Soc Med 54:327–329, 1961.
Smith CR, Chan HSL and de Sa DJ: Placental involvement in congenital neuroblastoma. J Clin Pathol 34:785–789, 1981.
Smith EI, Krous HF, Tunell WP and Hitch DC: The impact of chemotherapy and radiation therapy on secondary operations for neuroblastoma. Ann Surg 191:561–568, 1980.
Snyder WH Jr, Hastings TN and Pollock WF: Retroperitoneal tumors. IN. Pediatric Surgery. Volume 2, Second Edition, WT Mustard, MM Ravitch, WH Snyder, KJ Welch and CD Benson (eds), Year Book Medical Publishers, Chicago, pp 1039–1055.
Sober I and Hirsch M: Unilateral massive adrenal hemorrhage in newborn infant. J Urol 93:430–434, 1965
Solomon GE and Chutorian AM: Opsoclonus and occult neuroblastoma. New Engl J Med 279:475–477, 1968.
Sourkes TL, Denton RL, Murphy GF, Chaves B and Saint Cyr C: The excretion of dihydroxyphenylalanine, dopamine and dihydroxyphenylacetic acid in neuroblastoma. Pediatrics 31:660–668, 1963.
Spigelblatt L, Benoit P and Jacob JL: Neuroblastoma with heterochromia and Horner syndrome. J Pediatr 88:1067–1068, 1976 (Letter).
Spruce WE, Blume KG, Ellington OB, Schmidt GM and Zusman J: Syngeneic bone marrow transplantation in a patient with metastatic neuroblastoma refractory to conventional therapy. Pediatrics 65:573–574, 1980.
Staley NA, Polesky HF and Bensch KG: Fine structure and biochemical studies on the malignant ganglioneuroma. J Neuropathol Exp Neurol 26:634–653, 1967.
Stanley-Brown EG and Dargeon HW: Second-look operation for retroperitoneal cancer in childhood. New York State Med J 71:674–676, 1971.
Stark DD, Moss AA, Brasch RC, de Lorimier A, Ablin AA, London DA and Gooding CAL: Neuroblastoma: Diagnostic imaging and staging. Radiology 148:101–105, 1983.
Starling KA, Sutow WW, Donaldson MH, Land VJ and Lane DM: Drug trials in neuroblastoma: Cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone. Cancer Chemo Rep 58:683–688, 1974.
Stella JG, Schweisguth O and Schlienger M: Neuroblastoma. Am J Roentgenol 108:324–332, 1970.
Stevens MM: Stage IV-S neuroblastoma: Disseminated malignancy with a favourable prognosis. Three case reports. Aust Paediatr J 15:39–43, 1979.
Stewart HL, Snell KC, Dunham LJ and Schlyen SM: Transplantable and transmissable tumors of animals. Armed Forces Institute of Pathology, Washington. 1959, pp F40–336–F40–341.
Stickler GB and Flock EV: Neuroblastoma and ganglioneuroblastoma: Associated increased urinary excretion of catecholamines. Cancer Chemo Rep 16:439–442, 1962.
Stickler GB, Hallenbeck GA and Flock EV: Ganglioneuroblastoma associated with chronic diarrhea and increased excretion of catecholamines: Preliminary report. Proc Mayo Clinic 34:548–549, 1959.
Stickler GB, Hallenbeck GA, Flock EV and Rosevear JW: Catecholamines and diarrhea in ganglioneuroblastoma. Am J Dis Child 104:598–604, 1962.
Stokes SH, Thomas PRM, Perez CA and Vietti TJ: Stage IV-S neuroblastoma. Cancer 53:2083–2086, 1984.
Stout AP: Ganglioneuroma of the sympathetic nervous system. Surg Gynecol Obstet 84:101–110, 1947.
Strauss L and Driscoll SG: Congenital neuroblastoma involving the placenta. Pediatrics 34:23–31, 1964.
Sty JR, Babbit DP, Casper JT and Boedecker RA: 99m Tc-methylene diphosphonate imaging in neural crest tumors. Clin Nuc Med 4:12–17, 1979.
Sugimoto T, Tatsumi E, Kemshead JT, Belson L, Green AA and Minowada J: Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Nat Cancer Inst 73:51–57, 1984.
Sullivan MP, Nora AH, Kulapongs P, Lang DM, Windmiller J and Thurman G: Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma. Pediatrics 44:685–694, 1969.
Sutow WW: Prognosis in neuroblastoma of childhood. Am J Dis Child 96:299–305, 1958.
Sutow WW, Fernbach DJ, Thurman WG, Holton CP and Watkins WL: Daunomycin (NSC-82151) in the treatment of metastatic neuroblastoma. Cancer Chemo Rep 54:283–289, 1970.
Sutow WW, Wilbur JR, Vietti TJ, Vuthighagdee P, Fujimoto T and Watanabe A: Evaluation of dosage schedules of mitomycin C (NSC-26980) in children. Cancer Chemo Rep 55:285–289, 1971.
Swank RL II, Fetterman GH, Sieber WK and Kiesewetter WB: Prognostic factors in neuroblastoma. Ann Surg 174:428–435, 1971.
Swift PGF, Bloom SR and Harris F: Watery diarrhea and ganglioneuroma with secretion of vasoactive intestinal peptide. Arch Dis Child 50:896–899, 1975.
Sy WM and Edmonson JH: The developmental defects associated with neuroblastoma — Etiologic implications. Cancer 22:234–238, 1968.
Tan C, Rosen G, Ghavimi F, Haghbin M, Helson L, Wollner N and Murphy ML: Adriamycin (NSC-123127) in pediatric malignancies. Cancer Chemo Rep Part 36:259–266, 1975.
Tan C, Tasaka H, Yu K-P, Murphy ML and Karnofsky DA: Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Cancer 20:333–353, 1967.
Tan CTC and Aduna NS: Preliminary clinical experience with leurocristine in children. Proc Am Assoc Cancer Res 3:367, 1962 (Abstract).
Tan CTC, Dargeon HW and Burchenal JH: The effect of actinomycin D on cancer in childhood. Pediatrics 24:544–561, 1959.
Tan CTC, Hancock CH, Mondora A and Hoffman NW: Phase II study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer. Cancer Res 44:831–835, 1984.
Tang C-K and Hajdu SI: Neuroblastoma in adolescence and. adulthood. New York State J Med 75:1434–1438, 1975.
Taxy JB: Electron microscopy in the diagnosis of neuroblastoma. Arch Pathol Lab Med 104:355–360, 1980.
Tay JSH, Wee PH, Wong HB and Jacob E: The La Brosse spot test in the diagnosis of neuroblastoma. J Singapore Paediatr Soc 21:56–59, 1979.
Tazawa K, Soga J and Ito H: Fine structure of neuroblastoma. Acta Pathol Jap 21:257–270, 1971.
Teppo L: Personal communication.
Thomas PRM, Lee JY, Fineberg BB, Razek AA, Perez CA, Land VJ and Vietti TJ: An analysis of neuroblastoma at a single institution. Cancer 53:2079–2082, 1984.
Thompson EN and Bosley A: Disseminated intravascular coagulation in association with congenital neuroblastoma. Postgrad Med J 55:814–817, 1979.
Thurman WG and Donaldson MH: Current concepts in the management of neuroblastoma. IN. Neoplasia in Childhood. Year Book Medical Publishers, Chicago, 1969, pp 175–181
Thurman WG, Fernbach DJ and Sullivan MP: Cyclophosphamide therapy in childhood neuroblastoma. New Engl J Med 270:1336–1340, 1964.
Tiedemann K, Pritchard J, Long R and Bloom SR: Intractable diarrhea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Eur J Pediatr 137:217–219, 1981.
Traggis DG, Filler RM, Druekman H, Jaffe N and Cassady JR: Prognosis for children with neuroblastoma presenting with paralysis. J Pediatr Surg 12:419–425, 1977.
Travaglia M: Neuroblastoma: A twenty year review. NZ Med J 85:469–471, 1977.
Treleaven JG, Gibson FM, Ugelstad J, Rembaum A, Philip T, Caine GD and Kemshead JT: Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1:70–73, 1984.
Triche TJ and Askin FB: Neuroblastoma and the differential diagnosis of small-, round-, blue cell tumors. Human Pathol 14:569–595, 1983.
Triche TJ and Ross WE: Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing’s sarcoma. Cancer 41:1425–1432, 1978.
Tsokos M, Linnoila RI, Chandra RS and Triche TJ: Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Human Pathol 15:575–584, 1984.
Tsuchida Y, Yokomori K, Iwanaka T and Saito S: Nude mouse xenograft study for treatment of neuroblastoma: Effects of chemotherapeutic agents and surgery on tumor growth and cell kinetics. J Pediatr Surg 19:72–76, 1984.
Tumilowicz JJ, Nichols WW, Cholon JJ and Greene AE: Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30:2110–2118, 1970.
Uchino J, Hata Y and Kasai Y: Stage IV-S neuroblastoma. J Pediatr Surg 13:167–172, 1978.
Uhlmann EM and von Essen C: Neuroblastoma (Neuroblastoma sympatheticum). Pediatrics 15:402–411, 1955.
Valdes OS, Maurer HM and Shumway CN: Neuroblastoma. Virginia Med Mon 97:340–344, 1970.
van der Slikke JW and Balk AG: Hydramnios with hydrops fetalis and disseminated fetal neuroblastoma. Obstet Gynecol 55:250–253, 1980.
Van Way CW III, Carlisle RB and Stephenson SE Jr: Combined therapy of neuroblastoma. Ann Surg 167:856–865, 1968.
Varkarakis MJ, Bhanalaph T, Albert DJ, Sinks L and Murphy GP: Current status of prognostic criteria in neuroblastoma. J Urol 109:94–97, 1973.
Vauquelin G, Verheyden R, Ebinger G and Strosberg AD: Diazotization of catecholamines and their analogs and metabolites for urinary screening tests: Chemical aspects. Clin Chem 22:1955–1961, 1976.
Venugopal S and Shah DJ: Paratesticular neuroblastoma. West Ind Med J 30:215–218, 1981.
von Hoff DD, Casper J, Bradley E, Trent JM, Hodach A, Reichert C, Makuch R and Altman A: Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 40:3591–3597, 1980.
von Studnitz W: Homoserine in urine in patients with neuroblastoma. Scand J Clin Lab Invest 17:558–564, 1965.
von Studnitz W, Kaser H and Sjoerdsma A: Spectrum of catecholamine biochemistry in patients with neuroblastoma. New Engl J Med 269:232–235, 1963.
Voorhess ML: Neuroblastoma with normal urinary catecholamine excretion. J Pediatr 78:680–683, 1971.
Voorhess ML and Gardner LI: Catecholamine metabolism in neuroblastomas. Lancet 2:651–652, 1960 (Letter).
Voorhess ML and Gardner LI: Studies of catecholamine excretion by children with neural tumors. J Clin Endocrinol 22:126–133, 1962.
Voorhess ML and Gardner LI: The value of serial catecholamine determinations in children with neuroblastoma. Pediatrics 30:241–246, 1962.
Voorhess ML and Gardner LI: Urinary excretion of norepinephrine, epinephrine and 3-methoxy-4-hydroxymandelic acid by children with neuroblastoma. J Clin Invest 21:321–335, 1961.
Wagget J, Aherne G and Aherne W: Familial neuroblastoma: Report of two sib pairs. Arch Dis Child 48:63–66, 1973.
Wagner HP and Kaser H: Cell proliferation in neuroblastoma. Eur J Cancer 6:369–372, 1970.
Wajsman Z, Williams P and Murphy GP: A study of the effect of papaverine in neuroblastoma using the experimental C-1300 murine system. Oncology 35:1–4, 1978.
Wang JJ, Holland JF and Sinks LF: Phase II study of adriamycin (NSC-123127) in childhood solid tumors. Cancer Chemo Rep Part 36:267–270, 1975.
Waris T, Rechardt L and Waris P: Differentiation of neuroblastoma cells induced by nerve growth factor in vitro. Experientia 29:1128–1129, 1973.
Weetman RM, Rider PS, Oei TO, Hempel JS and Baehner RL: Effect of diet on urinary excretion of VMA, HVA, metanephrine and total free catecholamine in normal pre-school children. Pediatrics 88:46–50, 1976.
Weinblatt ME, Heisel MA and Siegel SE: Hypertension in children with neurogenic tumors. Pediatrics 71:947–951, 1983.
Weller MH and Miller K: Unusual aspects of urine ascites. Radiology 109:665–669, 1973.
West KW, Careskey JM, Grosfeld JL, Wells R, Weber TR and Baehner RL: Role of papaverine in the treatment of neuroblastoma. Surg Forum 32:444–446, 1981.
West KW, Weber TR and Grosfeld JL: Synergistic effect of hyperthermia, papaverine and chemotherapy in murine neuroblastoma. J Pediatr Surg 15:913–916, 1980.
Wharam MD, Kaizer H, Leventhal BG, Munoz L, Tutschka PJ, Santos GW, Elfenbein GJ and Order SE: Systemic irradiation for selected stage IV and recurrent pediatric solid tumors: Method, toxicity and preliminary results. Int J Rad Oncol Biol Phys 6:217–223, 1980.
White SJ, Stuck KJ, Blane CE and Silver TM: Sonography of neuroblastoma. Am J Roentgenol 141:465–468, 1983.
Whitehouse JMA and Holborow EJ: Smooth muscle antibody in malignant disease. Br Med J 4:511–513, 1971.
Williams CM and Greer M: Homovanillic acid and vanilmandelic acid in diagnosis of neuroblastoma. JAMA 183:836–840, 1963.
Williams TH, House RJ Jr, Burgert EO Jr and Lynn HB: Unusual manifestations of neuroblastoma: Chronic diarrhea, polymyoclonia-opsoclonus and erythrocyte abnormalities. Cancer 29:475–480, 1972.
Willis RA: Pathology of Tumours. Third Edition. Butterworths, Washington, 1960, p 848.
Willnow U: The kinetics of cell proliferation in neuroblastomas. Arch Geschwulstforsch 49:211–219, 1979.
Windmiller J, Berry DH, Haddy TB, Vietti TJ and Sutow WW: Vincristine sulfate in the treatment of neuroblastoma in children. Am J Dis Child 111:75–78, 1966.
Wittenborg MH: Roentgen therapy in neuroblastoma. Am J Roentgenol 54:679–687, 1950.
Witzleben CL and Lindy RA: Disseminated neuroblastoma in a child with von Recklinghausen’s disease. Cancer 34:786–790, 1974.
Wong K-Y, Hanenson IB and Lampkin BC: Familial neuroblastoma. Am J Dis Child 121:415–416, 1971.
Wright JH: Neurocytoma or neuroblastoma. A kind of tumor not generally recognized. J Exp Med 12:556–561, 1910.
Wyatt GM and Farber S: Neuroblastoma sympatheticum. Am J Roentgenol 46:485–495, 1941.
Yokomori K, Tsuchida Y and Saito S: Tyrosine hydroxylase and choline acetyltransf erase activity in human neuroblastoma. Cancer 52:263–272, 1983.
Yokoya S, Suda T, Koyama M, Yanagisawa M, Kamoshita S, Miyakawa K and Moriyama S: Retropharyngeal neuroblastoma causing airway obstruction in a newborn — Survival with surgical treatment alone. J Pediatr Surg 17:180–181, 1982.
Yokoyama M, Okada K, Tokue A, Takayasu H and Yamada R: Ultrastructural and biochemical study of neuroblastoma and ganglioneuroblastoma. Invest Urol 9:156–164, 1971.
Young JL: Personal communication.
Young JL Jr, Heise HW, Silverberg E and Myers MH: Cancer incidence, survival and mortality for children under 15 years of age. American Cancer Society, New York, 1978 p 8.
Young JL Jr and Miller RW: Incidence of malignant tumors in US children. J Pediatr 86:254–258, 1975.
Young RB, Steiker DD, Bongiovanni AM, Koop CE and Eberlein WR: Urinary vanilmandelic acid (VMA) excretion in children: Use of a simple semiquantitative test. J Pediatr 62:844–854, 1963.
Yunis EJ, Walpusk JA, Agostini RM Jr and Hubbard JD: Glycogen in neuroblastomas. Am J Surg Pathol 3:313–323, 1979.
Zauli D, Bianchi FB, Gardelli T, Volta U, Lenzi M, Mancini AF and Pisi E: Smooth-muscle antibodies in children with neuroblastoma. Cancer 46:497–499, 1980.
Zeltzer P, Marangos P, Sather H, Dalton A, Siegel S, Hammond D, Wong KY and Seeger R: Prognostic importance of neuron specific enolase levels in widespread and localized neuroblastoma. Proc Am Soc Clin Oncol 3:13, 1984 (Abstract).
Zeltzer PM, Marangos PJ, Parma AM, Sather H, Dalton A, Hammond D, Siegel SE and Seeger RC: Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 2:361–363, 1983.
Zeltzer P, Marangos P, Sather H, Dalton A, Siegel S, Hammond D, Wong KY and Seeger R: Prognostic importance of neuron specific enolase levels in widespread and localized neuroblastoma. Proc Am Soc Clin Oncol 3:13, 1984 (Abstract).
Zeltzer PM, Parma AM, Dalton A, Siegel SE, Marangos PJ, Sather H, Hammond D and Seeger RC: Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 2:361–363, 1983.
Zheng H-L, Maruyama T, Matsuda SK and Satomura K: Neuroblastoma presenting with nephrotic syndrome. J Pediatr Surg 14:414–419, 1979.
Ziter FA, Bray PF and Camilla PA: Neuropathologie findings in a patient with neuroblastoma and myoclonie encephalopathy. Arch Neurol 36:51, 1979.
Zucker JM and Margulis E: Radiochemotherapy of postoperative minimal residual disease in neuroblastoma. IN. Adjuvant Therapies and Markers of Post-surgical Minimal Residual Disease II. G Bonadonna, G Mathe and SE Salmon (eds). Springer-Verlag, Berlin, 1979, pp 423–430.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Green, D.M. (1985). Neuroblastoma. In: Diagnosis and Management of Malignant Solid Tumors in Infants and Children. Developments in Oncology, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2623-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2623-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9640-9
Online ISBN: 978-1-4613-2623-6
eBook Packages: Springer Book Archive